Reaction

Paranasal Sinus Inflammation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 214 reports · 4 co-occurring drugs

As of the last recalculation, Paranasal Sinus Inflammation appears in 214 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is DOXEPIN (PRR 177.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Doxepin17177.1177.4
Doxepin Hydrochloride20169.8170.1
Ciclesonide1398.898.9
Ranitidine Hydrochloride1733.033.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.